PP_1170x120_10-25-21

Q&A: HDA’s Chip Davis discusses sector sustainability

Q&A: HDA’s Chip Davis discusses sector sustainability

ARLINGTON, Va. — HDA recognizes the role health care distributors can play in minimizing the healthcare sector’s carbon footprint. Many members are already committing to sustainability initiatives — from adopting eco-friendly packaging to setting carbon neutrality goals. The efforts of HDA and its membership to enhance the healthcare distribution sector’s sustainability is reflected in HDA’s president

Pharmacy Outlook: Chip Davis, HDA

Pharmacy Outlook: Chip Davis, HDA

From the White House to the kitchen table, supply chain disruptions have been on the minds of many Americans. But while the COVID-19 pandemic revealed the limits of operating within a global marketplace, the pharmaceutical supply chain was largely immune to bottlenecks. Consumer goods shortages have challenged us recently, yet pharmacies, health systems and physicians’

Pharmacy Outlook: Chip Davis, HDA

Pharmacy Outlook: Chip Davis, HDA

Our nation is at a defining moment, as we transition to a new administration and Congress and continue to respond to the COVID-19 pandemic. From a health care delivery perspective, the logistics expertise of our industry has never been more relied upon, and scrutinized, than it is today. As the calendar turns to 2021, eradicating

Logistics will help win the battle against COVID-19

Logistics will help win the battle against COVID-19

Across the country, brave, frontline health care professionals are working around the clock as our nation grapples with the COVID-19 pandemic. These workers — the true heroes of the pandemic — are treating patients, maintaining vital health care operations and serving as emergency responders. In this time of crisis, it is also important to remember

Making the Rx markets more competitive again

Making the Rx markets more competitive again

Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. This past June, Secretary of Health and Human Services Alex Azar told the Senate Finance Committee, “We need a strong, robust generic market.” He followed this statement with an observation that resonated for many of the member companies of the